The NCN Investor Meeting is a unique platform allowing businesses and individuals to apply for the opportunity to present their business plans to strategic and private equity investors.
Taking place on Monday 8 May, NCN will present 15 professionally screened companies within nutrition ingredients, science and technology, to an audience of investors, with an opportunity for one-to-one meetings after the presentations.
Since it's founding in 2007, NCN has hosted over 30 investor meetings and has established a successful track record of matching companies with investors and partners. NCN counts Abbott Labs, DSM, GSK, Herbalife, Kerry Group, Naturex, Seventure, Suan Farma, SOHO Flordis International, Tate & Lyle Ventures and Zaluvia among its "Cornerstone Investors" at Vitafoods Europe.
Interested in Presenting?
NCN is now accepting applications from companies interested in presenting their business plans at Vitafoods Europe. Presenting companies should be seeking investment, acquisition, or corporate partnerships for technology development, comercialisation, clinical trials, distribution or licensing.
Finished product companies in consumer health, supplements or functional, natural and organic foods will also be considered as presenters.
Apply online to be a presenting company at NCN Europe or contact Executive Director at NCN, Mike Dovbish, Tel: 00 1 415 254 1116.
Interested in Investing?
Investors can register for NCN Europe by contacting NCN Meeting Chairman, Grant Ferrier. NCN registration is €1,000 and includes profiles of the presenting companies in advance of the meeting.
Please note: Investor attendees must register separately to attend Vitafoods Europe and will receive advance profiles of the presenting companies.